New Antituberculous Drugs
New Antituberculous Drugs. Hail M. Al-Abdely, MD Consultant, Infectious Diseases King Faisal Specialist Hospital and Research Center. Driving forces behind Drug development. Good market Common NOT rare (pseudomonas versus Burkhelderia) Common in the rich (HIV versus Tuberculosis)
535 views • 33 slides